You are using an older browser version. Please use a supported version for the best MSN experience.

FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk—Here's What That Means

Of the 100 preliminary reports of Guillain-Barré syndrome, 95 were serious.

UP NEXT

UP NEXT

More From Health.com

More From Health.com

image beaconimage beaconimage beacon